Effect of remifentanil on Sevoflurane MACbar in gynecological laparoscopic patients under CSI monitoring

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900020792

Enrollment

Unknown

Registered

2019-01-19

Start date

2019-01-14

Completion date

Unknown

Last updated

2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological laparoscopic surgery

Interventions

Case series:remifentanil on sevoflurane MACBAR

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Thirty patients undergoing elective gynecologic laparoscopic surgery were enrolled in the group: (1) ASA I to II; (2) aged 18 to 60 years old; (3) without major systemic diseases such as heart, lung, liver, kidney and blood; (4) No drugs affecting the circulatory system or blocking the sympathetic nerves were used within 1 month before surgery.

Exclusion criteria

Exclusion criteria: Perioperative HR < 50 beats / min, patients need to be treated with ephedrine.

Design outcomes

Primary

Measure	Time frame
Heart rate;Blood pressure;CSI (cerebral state index);	—

Secondary

Measure	Time frame
End-tidal sevoflurane concentration;	—

Countries

China

Contacts

Public ContactChen Zhanming

Department of Anesthesiology, Xiamen Chang Gung Hospital

chenzhanming2005@126.com+86 15359885510

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026